Clinical Trials · NCT07657676
Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- China National Center for Cardiovascular Diseases
- Enrollment
- 116
- Start date
- May 2026
- Locations
- 1 site, China
- Primary endpoint
- Change from baseline in total non-calcified plaque volume (NCPV) at 52 weeks measured by CCTA